Arkolith/Insider Trading/DCTH

DCTH Insider Trading

Delcath Systems, Inc. · full profile →Last filing May 13, 2026
Net Buying · 180d
Open-Market Buys (180d)
$150K
2 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$150K
open market, 180d
Reporting Insiders
2
2 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
May 13, 2026Sylvester John RichardDirectorGrant(A)23K—$0
May 13, 2026Martell Bridget ADirectorGrant(A)23K—$0
May 13, 2026Salamon Steven A JDirectorGrant(A)23K—$0
May 13, 2026Czerepak ElizabethDirectorGrant(A)23K—$0
May 13, 2026Aharon GilDirectorGrant(A)23K—$0
Mar 6, 2026Pennell SandraChief Financial OfficerBuy(P)6K$9.04$50K
Mar 2, 2026Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorBuy(P)11K$8.96$100K
Feb 17, 2026Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorGrant(A)98K—$0
Feb 17, 2026Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorGrant(A)195K—$0
Feb 17, 2026Vukovic VojoCHIEF MEDICAL OFFICERGrant(A)57K—$0
Feb 17, 2026Vukovic VojoCHIEF MEDICAL OFFICERGrant(A)28K—$0
Feb 17, 2026Pennell SandraChief Financial OfficerGrant(A)57K—$0
Feb 17, 2026Pennell SandraChief Financial OfficerGrant(A)28K—$0
Feb 17, 2026Muir KevinGM INTERVENTIONAL ONCOLOGYGrant(A)57K—$0
Feb 17, 2026Muir KevinGM INTERVENTIONAL ONCOLOGYGrant(A)28K—$0
Feb 17, 2026Hoffman David L.GEN'L COUNSEL, CCO & SECYGrant(A)57K—$0
Feb 17, 2026Hoffman David L.GEN'L COUNSEL, CCO & SECYGrant(A)28K—$0
Feb 17, 2026Rook Martha S.CHIEF OPERATING OFFICERGrant(A)57K—$0
Feb 17, 2026Rook Martha S.CHIEF OPERATING OFFICERGrant(A)28K—$0
Nov 21, 2025Sylvester John RichardDirectorBuy(P)4K$8.89$39K
Nov 11, 2025Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorBuy(P)12K$8.53$98K
Jun 12, 2025Vukovic VojoCHIEF MEDICAL OFFICEROption exercise(M)42K$4.78$201K
Jun 12, 2025Vukovic VojoCHIEF MEDICAL OFFICEROption exercise(M)42K—$0
May 15, 2025Martell Bridget ADirectorGrant(A)23K—$0
May 15, 2025Aharon GilDirectorGrant(A)23K—$0
May 15, 2025Czerepak ElizabethDirectorGrant(A)23K—$0
May 15, 2025Salamon Steven A JDirectorGrant(A)23K—$0
May 15, 2025Sylvester John RichardDirectorGrant(A)23K—$0
May 5, 2025Salamon Steven A JDirectorOption exercise(X)400K$10.00$4.0M
May 5, 2025Salamon Steven A JDirectorOption exercise(X)400K$10.00$4.0M
May 5, 2025Aharon GilDirectorOption exercise(X)400K$10.00$4.0M
Feb 7, 2025Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorGrant(A)390K—$0
Feb 7, 2025Vukovic VojoCHIEF MEDICAL OFFICERGrant(A)113K—$0
Feb 7, 2025Rook Martha S.CHIEF OPERATING OFFICERGrant(A)113K—$0
Feb 7, 2025Muir KevinGM INTERVENTIONAL ONCOLOGYGrant(A)113K—$0
Feb 7, 2025Pennell SandraChief Financial OfficerGrant(A)113K—$0
Feb 7, 2025Hoffman David L.GEN'L COUNSEL, CCO & SECYGrant(A)113K—$0
Dec 24, 2024Rosalind Advisors, Inc.DirectorConversion(C)250K$10.00$2.5M
Dec 24, 2024Rosalind Advisors, Inc.DirectorOption exercise(M)604K$9.99$6.0M
Dec 24, 2024Salamon Steven A JDirectorConversion(C)250K$10.00$2.5M
Dec 24, 2024Salamon Steven A JDirectorOption exercise(M)604K$9.99$6.0M
Dec 24, 2024Aharon GilDirectorConversion(C)250K$10.00$2.5M
Dec 24, 2024Aharon GilDirectorOption exercise(M)604K$9.99$6.0M
Oct 30, 2024Salamon Steven A JDirectorOption exercise(M)500$1,000.00$500K
Oct 30, 2024Salamon Steven A JDirectorExpiration(H)0—$0
Oct 30, 2024Salamon Steven A JDirectorOption exercise(M)500$1,000.00$500K
Oct 30, 2024Salamon Steven A JDirectorExpiration(H)0—$0
Oct 30, 2024Aharon GilDirectorExpiration(H)0—$0
Oct 30, 2024Aharon GilDirectorOption exercise(M)500$1,000.00$500K
Oct 22, 2024Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorOption exercise(M)17K$6.00$100K
Oct 22, 2024Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorOption exercise(M)17K$0.13$2K
May 23, 2024Stoll Roger G PHDDirectorDisposed to issuer(D)142—$0
May 23, 2024Stoll Roger G PHDDirectorGrant(A)142—$0
May 23, 2024Stoll Roger G PHDDirectorDisposed to issuer(D)40K—$0
May 23, 2024Stoll Roger G PHDDirectorGrant(A)40K—$0
May 23, 2024Stoll Roger G PHDDirectorDisposed to issuer(D)9K—$0
May 23, 2024Stoll Roger G PHDDirectorGrant(A)9K—$0
May 23, 2024Stoll Roger G PHDDirectorDisposed to issuer(D)9K—$0
May 23, 2024Stoll Roger G PHDDirectorGrant(A)9K—$0
May 23, 2024Stoll Roger G PHDDirectorDisposed to issuer(D)20K—$0
May 23, 2024Stoll Roger G PHDDirectorGrant(A)20K—$0
May 23, 2024Martell Bridget ADirectorGrant(A)23K—$0
May 23, 2024Aharon GilDirectorGrant(A)23K—$0
May 23, 2024Salamon Steven A JDirectorGrant(A)23K—$0
May 23, 2024Sylvester John RichardDirectorGrant(A)23K—$0
May 23, 2024Czerepak ElizabethDirectorGrant(A)23K—$0
Apr 18, 2024Rosalind Advisors, Inc.DirectorOption exercise(X)620K$6,199.46$3.8B
Apr 18, 2024Rosalind Advisors, Inc.DirectorConversion(C)992K—$0
Apr 18, 2024Aharon GilDirectorConversion(C)992K—$0
Apr 18, 2024Aharon GilDirectorOption exercise(X)620K$0.01$6K
Apr 18, 2024Salamon Steven A JDirectorConversion(C)992K—$0
Apr 18, 2024Salamon Steven A JDirectorOption exercise(X)620K$0.01$6K
Apr 18, 2024Aharon GilDirectorConversion(C)992K—$0
Apr 18, 2024Aharon GilDirectorOption exercise(X)620K$6,199.46$3.8B
Apr 18, 2024Aharon GilDirectorConversion(C)992K—$0
Apr 18, 2024Aharon GilDirectorOption exercise(X)620K$0.01$6K
Mar 19, 2024Hoffman David L.GEN'L COUNSEL, CCO & SECYGrant(A)20K$3.72$75K
Mar 19, 2024Muir KevinGM INTERVENTIONAL ONCOLOGYGrant(A)13K$3.72$50K
Mar 19, 2024Pennell SandraSVP OF FINANCE, PFO AND PAOGrant(A)27K$3.72$100K
Mar 19, 2024Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorGrant(A)40K$3.72$150K
Mar 19, 2024Vukovic VojoCHIEF MEDICAL OFFICERGrant(A)27K$3.72$100K
Mar 19, 2024Salamon Steven A JDirectorBuy(P)620K$3.71$2.3M
Mar 19, 2024Salamon Steven A JDirectorBuy(P)27K$3.72$100K
Mar 19, 2024Aharon GilDirectorBuy(P)27K$3.72$100K
Mar 18, 2024Rook Martha S.CHIEF OPERATING OFFICERGrant(A)125K—$0
Feb 12, 2024Hoffman David L.GEN'L COUNSEL, CCO & SECYGrant(A)101K—$0
Feb 12, 2024Pennell SandraSVP OF FINANCE, PFO AND PAOGrant(A)101K—$0
Feb 12, 2024Muir KevinVP COMMERCIAL OPERATIONSGrant(A)101K—$0
Feb 12, 2024Michel Gerard JCHIEF EXECUTIVE OFFICER, DirectorGrant(A)302K—$0
Feb 12, 2024Vukovic VojoCHIEF MEDICAL OFFICERGrant(A)101K—$0
Dec 12, 2023Vukovic VojoChief Medical OfficerBuy(P)40K$3.00$120K
Dec 8, 2023Michel Gerard JChief Executive Officer, DirectorBuy(P)34K$2.94$100K
Nov 17, 2023Pennell SandraSVP of Finance, PFO and PAOBuy(P)30K$2.43$73K
Nov 17, 2023Rosalind Advisors, Inc.DirectorBuy(P)100K$2.40$240K
Nov 16, 2023Hoffman David L.See RemarksBuy(P)40K$2.48$99K
Nov 16, 2023Vukovic VojoChief Medical OfficerBuy(P)60K$2.48$149K
Oct 13, 2023Purpura JohnChief Operating OfficerBuy(P)15K$3.44$50K
Aug 21, 2023Sylvester John RichardDirectorBuy(P)11K$4.80$51K
Aug 21, 2023Aharon GilDirectorOption exercise(X)0$1,000.00$0
Aug 18, 2023Michel Gerard JChief Executive Officer, DirectorOption exercise(X)31K$4.50$140K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).